ATE41604T1 - Arzneimittel zur oralen verabreichung, bestehend einerseits aus 9-alpha,11-beta-dichlor-16-alphamethyl-21-oxycarbonyldicyclohexyl-methyloxypregna-1,4-diene-3,20-dione als wirksubstanz und andererseits aus einem inerten pharmazeutischen exipiens, das die wirksamkeit des produkts im rektum oder im kolon sich entfalten laesst, sowie die verwendung dieser wirksubstanz zur - Google Patents
Arzneimittel zur oralen verabreichung, bestehend einerseits aus 9-alpha,11-beta-dichlor-16-alphamethyl-21-oxycarbonyldicyclohexyl-methyloxypregna-1,4-diene-3,20-dione als wirksubstanz und andererseits aus einem inerten pharmazeutischen exipiens, das die wirksamkeit des produkts im rektum oder im kolon sich entfalten laesst, sowie die verwendung dieser wirksubstanz zurInfo
- Publication number
- ATE41604T1 ATE41604T1 AT85400612T AT85400612T ATE41604T1 AT E41604 T1 ATE41604 T1 AT E41604T1 AT 85400612 T AT85400612 T AT 85400612T AT 85400612 T AT85400612 T AT 85400612T AT E41604 T1 ATE41604 T1 AT E41604T1
- Authority
- AT
- Austria
- Prior art keywords
- hand
- product
- substance
- rectum
- colon
- Prior art date
Links
- 210000001072 colon Anatomy 0.000 title abstract 3
- 210000000664 rectum Anatomy 0.000 title abstract 3
- 239000013543 active substance Substances 0.000 title 1
- 229940126601 medicinal product Drugs 0.000 title 1
- 239000000126 substance Substances 0.000 title 1
- 241001465754 Metazoa Species 0.000 abstract 2
- QIEPWCSVQYUPIY-LEKSSAKUSA-N Delta(1)-progesterone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 QIEPWCSVQYUPIY-LEKSSAKUSA-N 0.000 abstract 1
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8405222A FR2561919B1 (fr) | 1984-04-03 | 1984-04-03 | Composition pharmaceutique constituee d'une part, a titre de principe actif, par la 9a,11b-dichloro 16a-methyl 21-oxycarbonyldicyclohexyl methyloxy pregna-1,4-diene 3,20-dione et d'autre part, par un excipient pharmaceutique inerte apte a permettre l'action du produit dans le rectum ou le colon |
| EP85400612A EP0161144B1 (de) | 1984-04-03 | 1985-03-28 | Arzneimittel zur oralen Verabreichung, bestehend einerseits aus 9-alpha,11-beta-Dichlor-16-alpha-methyl-21-oxycarbonyldicyclohexyl-methyloxy-pregna-1,4-diene-3,20-dione als Wirksubstanz und andererseits aus einem inerten pharmazeutischen Exipiens, das die Wirksamkeit des Produkts im Rektum oder im Kolon sich entfalten lässt, sowie die Verwendung dieser Wirksubstanz zur Herstellung eines solchen Mittels |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE41604T1 true ATE41604T1 (de) | 1989-04-15 |
Family
ID=9302777
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT85400612T ATE41604T1 (de) | 1984-04-03 | 1985-03-28 | Arzneimittel zur oralen verabreichung, bestehend einerseits aus 9-alpha,11-beta-dichlor-16-alphamethyl-21-oxycarbonyldicyclohexyl-methyloxypregna-1,4-diene-3,20-dione als wirksubstanz und andererseits aus einem inerten pharmazeutischen exipiens, das die wirksamkeit des produkts im rektum oder im kolon sich entfalten laesst, sowie die verwendung dieser wirksubstanz zur |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US4614736A (de) |
| EP (1) | EP0161144B1 (de) |
| JP (1) | JPS60224615A (de) |
| AT (1) | ATE41604T1 (de) |
| AU (1) | AU571073B2 (de) |
| CA (1) | CA1226817A (de) |
| DE (1) | DE3568944D1 (de) |
| DK (1) | DK164478C (de) |
| FR (1) | FR2561919B1 (de) |
| GR (1) | GR850815B (de) |
| HU (1) | HU196122B (de) |
| IL (1) | IL74642A (de) |
| MA (1) | MA20388A1 (de) |
| OA (1) | OA07978A (de) |
| PT (1) | PT80214B (de) |
| ZA (1) | ZA851927B (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8909559D0 (en) * | 1989-04-26 | 1989-06-14 | Smith Kline French Lab | Pharmaceutical compositions |
| US5578576A (en) * | 1994-09-02 | 1996-11-26 | Dalhousie University | Method and composition for treating intestinal wounds or ulcers |
| US20050059583A1 (en) | 2003-09-15 | 2005-03-17 | Allergan, Inc. | Methods of providing therapeutic effects using cyclosporin components |
| US7151085B2 (en) | 2004-11-15 | 2006-12-19 | Allergan, Inc. | Therapeutic methods using cyclosporine components |
| US7135455B2 (en) * | 2004-11-15 | 2006-11-14 | Allergan, Inc | Methods for the therapeutic use of cyclosporine components |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2462443A1 (fr) * | 1979-07-26 | 1981-02-13 | Roussel Uclaf | Nouveau derive halogene de la serie du 16a-methyl pregnane, son procede de preparation et son application comme medicament |
| FR2471186A1 (fr) * | 1979-12-10 | 1981-06-19 | Roussel Uclaf | Nouveaux comprimes a delitescence colique, ainsi que leur procede de preparation |
| FR2533928A1 (fr) * | 1982-10-05 | 1984-04-06 | Roussel Uclaf | Nouveaux derives dichlores de la serie du 16a-methyl pregnane, leur procede de preparation et leur application comme medicaments |
-
1984
- 1984-04-03 FR FR8405222A patent/FR2561919B1/fr not_active Expired
-
1985
- 1985-03-14 ZA ZA851927A patent/ZA851927B/xx unknown
- 1985-03-19 IL IL74642A patent/IL74642A/xx unknown
- 1985-03-26 MA MA20612A patent/MA20388A1/fr unknown
- 1985-03-28 AT AT85400612T patent/ATE41604T1/de not_active IP Right Cessation
- 1985-03-28 DE DE8585400612T patent/DE3568944D1/de not_active Expired
- 1985-03-28 EP EP85400612A patent/EP0161144B1/de not_active Expired
- 1985-04-01 GR GR850815A patent/GR850815B/el unknown
- 1985-04-01 DK DK146785A patent/DK164478C/da not_active IP Right Cessation
- 1985-04-01 JP JP60066731A patent/JPS60224615A/ja active Pending
- 1985-04-01 US US06/718,175 patent/US4614736A/en not_active Expired - Fee Related
- 1985-04-02 PT PT80214A patent/PT80214B/pt not_active IP Right Cessation
- 1985-04-02 HU HU851257A patent/HU196122B/hu not_active IP Right Cessation
- 1985-04-02 CA CA000478163A patent/CA1226817A/fr not_active Expired
- 1985-04-03 AU AU40800/85A patent/AU571073B2/en not_active Ceased
- 1985-04-03 OA OA58554A patent/OA07978A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HU196122B (en) | 1988-10-28 |
| AU4080085A (en) | 1985-10-10 |
| PT80214A (en) | 1985-05-01 |
| OA07978A (fr) | 1987-01-31 |
| HUT44436A (en) | 1988-03-28 |
| CA1226817A (fr) | 1987-09-15 |
| MA20388A1 (fr) | 1985-10-01 |
| ZA851927B (en) | 1986-04-30 |
| IL74642A0 (en) | 1985-06-30 |
| US4614736A (en) | 1986-09-30 |
| FR2561919A1 (fr) | 1985-10-04 |
| JPS60224615A (ja) | 1985-11-09 |
| PT80214B (en) | 1987-02-17 |
| DK146785A (da) | 1985-10-04 |
| IL74642A (en) | 1988-09-30 |
| EP0161144A1 (de) | 1985-11-13 |
| DK164478B (da) | 1992-07-06 |
| AU571073B2 (en) | 1988-03-31 |
| DK146785D0 (da) | 1985-04-01 |
| EP0161144B1 (de) | 1989-03-22 |
| DE3568944D1 (en) | 1989-04-27 |
| DK164478C (da) | 1992-11-23 |
| GR850815B (de) | 1985-07-23 |
| FR2561919B1 (fr) | 1986-12-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0147261A3 (en) | Medicine and medicinal composition for the treatment and the prevention of skin affections involving an inflammation process | |
| DE59108854D1 (de) | Arzneimittel sowie deren herstellung und deren verwendung bei der bekämpfung von schmerzen und/oder entzündungen an tieren und menschen | |
| ES2040257T3 (es) | Composicion cosmetica. | |
| ES2141706T3 (es) | Formulaciones y su empleo en el tratamiento de enfermedades neurologicas. | |
| BG60253B1 (bg) | Човешки тъканен плазминогенен активатор | |
| EP0151989A3 (en) | Means for the treatment of cardiac diseases | |
| IT8167334A0 (it) | Dispositivo ortopedico atto ad essere impiegato per la prevenzione ela cura delle malattie del piede | |
| IE802589L (en) | Anti-inflammatory pharmaceutical composition containing¹rosmarinic acid | |
| FR2510889B1 (fr) | Medicament contenant certains phosphates ribofurannosyl-3',5'-cycliques substitues en 6, 8 pour le traitement de maladies proliferatives de la peau | |
| ATE126061T1 (de) | Verwendung von lithium zur behandlung oder prophylaxe von molluscum contagiusum. | |
| ATE41604T1 (de) | Arzneimittel zur oralen verabreichung, bestehend einerseits aus 9-alpha,11-beta-dichlor-16-alphamethyl-21-oxycarbonyldicyclohexyl-methyloxypregna-1,4-diene-3,20-dione als wirksubstanz und andererseits aus einem inerten pharmazeutischen exipiens, das die wirksamkeit des produkts im rektum oder im kolon sich entfalten laesst, sowie die verwendung dieser wirksubstanz zur | |
| ATE69550T1 (de) | Salicylsaeurehaltiges mittel gegen schuppende hauterkrankungen. | |
| EP0279867A3 (de) | Verwendung von Vitamin-E und Vitamin-E-Kombination mit nichtsteroidalen Antirheumatika und Schmerzmittel zur Behandlung von rheumatischen Erkrankungen | |
| ES8603270A1 (es) | Procedimiento para preparar liposomas que contiene alergenoso fracciones de alergenos inhalables | |
| EG14024A (en) | Pharmaceutical compositions and their use in the profyloxis and or treatment of certain diseases | |
| IT1170238B (it) | Impiego di ibuprofene e flurbiprofene nella cura dell'erpete | |
| Mardjuadi et al. | Double-blind trial comparing bufexamac infiltrations with triamcinolone acetonide infiltrations in patients with periarthritis of the shoulder | |
| Ferrigno | A Study of the Topical Administration of Hydrocortisone Acetate, 9‐alpha‐Fluorohydrocortisone Acetate and Pyridoxine Hydrochloride Upon Oral Lesions | |
| ATE2999T1 (de) | Xanthinderivate und pharmazeutische zusammensetzung zur verwendung fuer die behandlung chronischer verstopfungen der atemwege und von herzkrankheiten. | |
| BE888533A (fr) | Compositions pharmaceutiques et procedes pour le traitement de l'inflammation de tissus dermiques, | |
| IT1151729B (it) | Preparazione di soluzioni iniettabili di actinina impiegabili nella terapia umana come antalgico per il trattamento del dolore da neoplasie ed altre affezioni |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |